Great people form the core of any great organization. PreludeDx is always looking for highly qualified people with a passion for improving the lives of cancer patients. We will periodically post information about openings but are always interested in hearing from those who believe in our mission and values.
DCISionRT—Background of Assay, Supporting Evidence/Data, Outcomes
Jim Pellicane, MD
Breast Cancer Surgeon
Director of Breast Oncology
Bon Secours Cancer Institute
15:50
Introduction
16:16
Surgeon’s clinical dilemma to assessing risk in DCIS patients
22:57
Why is ER not a good indicator of risk assessment?
24:13
Why is patient age is no an independent predictor of risk?
25:23
What are side effects of RT, especially for younger patients?
26:20
What are the surgical options and decisions impacted by RT?
27:11
Case Studies
36:00
Personal lessons learned
39:18
What is the impact of hormone therapy on DCISionRT score?
Christy Kesslering, MD
Radiation Oncologist, Breast Cancer Specialist
Radiation Oncology Consultants
Northwester Medicine Radiation Oncology, Warrenville
39:55
Introduction
40:04
Clinical dilemma: Am I seeing all the patients? When do surgeons refer patients to me?
50:04
Why Tumor Grade and RTOG9804 Classification is not always the best indicator of Risk?
51:23
Case Studies
52:15
Clinical Application of DCISionRT testing for DCIS patients
53:08
Why should DCISionRT be ordered for every patient?
55:20
How genomic testing can help guide intensification and de-escalation of RT
56:52
Challenges and solution insights for radiation oncologists to use genomics in DCIS
Q and A with the Panelists
59:22
Why is 0.8 that DCISionRT common score? Answered by Christy
1:00:46
Turn-around-time and Billing. Answered by Dr. Pellicane
1:01:43
How do you build consensus/buy-in within your medical group/colleagues to implement a DCIS protocol between radiation oncologists and surgeons? Answered by Dr. Pellicane and Dr. Kesslering
1:03:20
Why order DCISionRT on all my DCIS patients? Answered by Dr. Kesslering
1:04:28
What are the results and implications of interaction studies between DCISion Score and RT? Answered by Dr. Bremer
105:59
Conclusion
SHARE Cancer Support: DCIS Recurrence and Radiation
Narrator: Dr. Troy Bremer
Want to know when our next webinar will be posted?
Enter your email and we’ll put you on our webinar notification list.